These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38027182)

  • 21. Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network.
    Hellwege JN; Stallings S; Torstenson ES; Carroll R; Borthwick KM; Brilliant MH; Crosslin D; Gordon A; Hripcsak G; Jarvik GP; Linneman JG; Devi P; Peissig PL; Sleiman PAM; Hakonarson H; Ritchie MD; Verma SS; Shang N; Denny JC; Roden DM; Velez Edwards DR; Edwards TL
    Sci Rep; 2019 Apr; 9(1):6077. PubMed ID: 30988330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between sarcopenia-related traits and cardiovascular diseases: a bi-directional Mendelian randomization study.
    Liu X; Wang Y; Wang Z; Li L; Yang H; Liu J; Li Z
    Front Endocrinol (Lausanne); 2023; 14():1237971. PubMed ID: 37900136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas.
    Yue L; Wang T; Ge Y; Ge M; Zhang C; Hou Q; Wang W; Tian H; Ren B; Du B; Zhang W
    Prostate; 2019 Feb; 79(3):312-319. PubMed ID: 30450670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.
    Yin Z; Yang JR; Rao JM; Song W; Zhou KQ
    Asian J Androl; 2015; 17(5):826-30. PubMed ID: 25677137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males.
    Chen W; Man S; Wang B; Kadeerhan G; Huang X
    Low Urin Tract Symptoms; 2022 May; 14(3):170-177. PubMed ID: 34882977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of bi-directional causal association between periodontitis and benign prostatic hyperplasia: epidemiological studies and two-sample mendelian randomization analysis.
    Wei H; Tian G; Xu S; Du Y; Li M; Wang Y; Deng J; Quan C
    Front Genet; 2024; 15():1326434. PubMed ID: 38716069
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
    Qian X; Xu D; Liu H; Lin X; Yu Y; Kang J; Sheng X; Xu J; Zheng S; Xu D; Qi J
    Aging Male; 2017 Dec; 20(4):250-256. PubMed ID: 28787260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic susceptibility of benign prostatic hyperplasia.
    Sanda MG; Beaty TH; Stutzman RE; Childs B; Walsh PC
    J Urol; 1994 Jul; 152(1):115-9. PubMed ID: 7515446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP1A1 gene polymorphism and heavy metal analyses in benign prostatic hyperplasia and prostate cancer: An explorative case-control study.
    Singh V; Madeshiya AK; Ansari NG; Singh MK; Abhishek A
    Urol Oncol; 2023 Aug; 41(8):355.e9-355.e17. PubMed ID: 37277283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression and sarcopenia: a Mendelian randomization analysis.
    Lu Y; Zhang R; Zheng Q
    Psychiatr Genet; 2023 Aug; 33(4):145-151. PubMed ID: 37463392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
    Na R; Helfand BT; Chen H; Conran CA; Crawford SE; Hayward SW; Tammela TLJ; Hoffman-Bolton J; Zheng SL; Walsh PC; Schleutker J; Platz EA; Isaacs WB; Xu J
    Prostate; 2017 Aug; 77(11):1213-1220. PubMed ID: 28656603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia.
    Chung GE; Yim JY; Kim D; Kwak MS; Yang JI; Park B; An SJ; Kim JS
    J Korean Med Sci; 2020 Jun; 35(22):e164. PubMed ID: 32508064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Blood Press; 1999; 8(1):29-36. PubMed ID: 10412880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
    Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
    Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review and meta-analysis of candidate gene association studies of benign prostate hyperplasia.
    Lin L; Li P; Liu X; Xie X; Liu L; Singh AK; Singh HN
    Syst Rev; 2022 Apr; 11(1):60. PubMed ID: 35382870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoporosis and sarcopenia-related traits: A bi-directional Mendelian randomization study.
    Liu C; Liu N; Xia Y; Zhao Z; Xiao T; Li H
    Front Endocrinol (Lausanne); 2022; 13():975647. PubMed ID: 36187130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role of glutathione S-transferase P1 gene polymorphism and metabolic syndrome in lower urinary tract symptoms attributed to benign prostatic hyperplasia.
    Zhang W; Li Z; Liu M; Mu Y; He J; Chen P; Liu D; Chen K; Che B; Xu S; Zhang H; Tang K
    World J Urol; 2021 Dec; 39(12):4413-4419. PubMed ID: 34228163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis.
    Luo J; Dunn T; Ewing C; Sauvageot J; Chen Y; Trent J; Isaacs W
    Prostate; 2002 May; 51(3):189-200. PubMed ID: 11967953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia.
    Pang Y; Li H; Gong Y; Jing S; Peng C; Liu W; Zhao Y; Wang H; Kaushik D; Rodriguez R; Wang Z
    Oncol Rep; 2019 Apr; 41(4):2491-2501. PubMed ID: 30816510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.